In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract
暂无分享,去创建一个
I. Blomfield | H. Mobley | D. Johnson | David E. Johnson | Hui-ping Zhao | Xin Li | H. Zhao | X. Li | Ian Blomfield
[1] H. Mobley,et al. Proteus mirabilis urease: operon fusion and linker insertion analysis of ure gene organization, regulation, and function , 1995, Journal of bacteriology.
[2] R. Belas,et al. Swarming and pathogenicity of Proteus mirabilis in the urinary tract. , 1995, Trends in microbiology.
[3] I. Blomfield,et al. The leucine-responsive regulatory protein binds to the fim switch to control phase variation of type 1 fimbrial expression in Escherichia coli K-12 , 1994, Journal of bacteriology.
[4] R. Russell,et al. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection , 1994, Infection and immunity.
[5] H. Mobley,et al. Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression , 1994, Journal of bacteriology.
[6] L. Emödy,et al. The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis. , 1994, The Journal of infectious diseases.
[7] P. Klemm,et al. Localization of promoters in the fim gene cluster and the effect of H-NS on the transcription of fimB and fimE. , 1994, FEMS microbiology letters.
[8] H. Mobley,et al. Proteus mirabilis MR/P fimbriae: molecular cloning, expression, and nucleotide sequence of the major fimbrial subunit gene , 1993, Journal of bacteriology.
[9] M. S. McClain,et al. Lrp stimulates phase variation of type 1 fimbriation in Escherichia coli K-12 , 1993, Journal of bacteriology.
[10] M. Gribskov,et al. The sigma 70 family: sequence conservation and evolutionary relationships , 1992, Journal of bacteriology.
[11] H. Mobley,et al. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection , 1991, Infection and immunity.
[12] M. S. McClain,et al. Type 1 fimbriation and fimE mutants of Escherichia coli K-12 , 1991, Journal of bacteriology.
[13] M. S. McClain,et al. Type 1 fimbriae mutants of Escherichia coli K12: characterization of recognized afimbriate strains and construction of new fim deletion mutants , 1991, Molecular microbiology.
[14] P. Zunino,et al. Antigenic and immunogenic activity of flagella and fimbriae preparations from uropathogenic Proteus mirabilis. , 1991, Canadian journal of microbiology.
[15] H. Holthöfer,et al. Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract , 1990, Infection and immunity.
[16] H. Mobley,et al. Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources. , 1990, The Journal of infectious diseases.
[17] P. Klemm,et al. Regulation of the phase switch controlling expression of type 1 fimbriae in Escherichia coli , 1989, Molecular microbiology.
[18] A. Schaeffer,et al. In vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infections , 1989, Infection and immunity.
[19] M. Chamberlin,et al. Structure and function of bacterial sigma factors. , 1988, Annual review of biochemistry.
[20] H. Mobley,et al. Urease-positive bacteriuria and obstruction of long-term urinary catheters , 1987, Journal of clinical microbiology.
[21] A. Siitonen,et al. Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. , 1987, The Journal of infectious diseases.
[22] H. Mobley,et al. Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. , 1987, The Journal of urology.
[23] D. Friedman,et al. Integration host factor is required for the DNA inversion that controls phase variation in Escherichia coli. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. Simons,et al. Improved single and multicopy lac-based cloning vectors for protein and operon fusions. , 1987, Gene.
[25] J. Abraham,et al. Fimbrial phase variation and DNA rearrangements in uropathogenic isolates of Escherichia coli. , 1986, Molecular biology & medicine.
[26] P. Klemm,et al. Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. , 1986, The EMBO journal.
[27] J. Abraham,et al. An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[28] U. Setia,et al. Bacteremia in a long-term care facility. Spectrum and mortality. , 1984, Archives of internal medicine.
[29] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[30] R. Freter,et al. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin , 1983, Infection and immunity.
[31] W. Anthony,et al. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. , 1982, The Journal of infectious diseases.
[32] R. Adegbola,et al. Haemagglutinins and fimbriae of Morganella, Proteus and Providencia. , 1982, Journal of medical microbiology.
[33] B. Eisenstein. Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control. , 1981, Science.
[34] S. Cohen,et al. Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. , 1980, Journal of molecular biology.
[35] I. Ofek,et al. Influence of pili on the virulence of Proteus mirabilis in experimental hematogenous pyelonephritis. , 1978, The Journal of infectious diseases.
[36] D. Musher,et al. Urease. The primary cause of infection-induced urinary stones. , 1976, Investigative urology.
[37] W. Faulk,et al. An immunocolloid method for the electron microscope. , 1971, Immunochemistry.